Randomized phase II study of clinical impact of ghrelin in esophageal cancer patients with cisplatin-based chemotherapy.
Not Applicable
- Conditions
- patients with advanced esophageal cancer, undergoing chemotherapy
- Registration Number
- JPRN-UMIN000004984
- Lead Sponsor
- Department of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients ineligible for inclusion were those with severe co morbid conditions, other active malignancy. Patients in this study had no obstruction by tumor, adequate oral intake, and no severe weight loss.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method